🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Inari Medical CFO sells over $275k in company stock

Published 2024-05-15, 04:46 p/m
NARI
-

In a recent move, Mitch C. Hill, the Chief Financial Officer of Inari Medical, Inc. (NASDAQ:NARI), sold a significant portion of his holdings in the company. On May 13, 2024, Hill engaged in multiple transactions involving the sale of Inari Medical's common stock, which collectively amounted to over $275,000.

According to the details of the transactions, Hill sold 300 shares at a weighted average price of $44.49, with individual trades within this batch ranging from $44.02 to $44.95. Additionally, he sold 3,500 shares at a weighted average price of $45.73, with prices varying from $45.37 to $46.23. The final batch consisted of 2,200 shares sold at an average of $46.55 per share, with a price range from $46.39 to $46.93.

These sales were conducted under a Rule 10b5-1 trading plan, which Hill had adopted on November 9, 2023. Such plans allow company insiders to set up a predetermined schedule for buying or selling stocks at a time when they are not in possession of nonpublic information, providing a defense against accusations of insider trading.

On the same date, Hill also acquired 6,000 shares of common stock at a price of $0.457 per share through the exercise of options. However, this transaction did not impact the total sale value reported.

Following these transactions, Hill's ownership in Inari Medical has seen a reduction, but he still holds a substantial number of shares directly and indirectly through family members. The company, which specializes in surgical and medical instruments and apparatus, has its headquarters in Irvine, California, and is incorporated in Delaware.

Investors and the market often closely watch insider transactions as they can provide insights into the executives' confidence in the company's future performance. However, it's essential to note that such transactions do not necessarily indicate a change in company fundamentals and can be motivated by various personal financial considerations.

InvestingPro Insights

As Inari Medical's CFO Mitch C. Hill adjusts his stake in the company, investors might be curious about the financial health and market performance of Inari Medical, Inc. (NASDAQ:NARI). According to InvestingPro data, Inari Medical has a market capitalization of approximately $2.73 billion. The company's gross profit margin is notably strong, standing at 87.67% over the last twelve months as of Q1 2024, underscoring their ability to maintain profitability on their products and services.

Despite not paying dividends, Inari Medical has shown a significant return over the last week, with a price total return of 8.8%, and an even more robust return over the last month at 15.22%. These metrics suggest that the company's stock has recently gained traction among investors. However, it's worth noting that Inari Medical is trading at a high Price / Book multiple of 6.11, which could indicate that the stock is valued relatively high compared to the company's book value.

Two InvestingPro Tips that could be particularly relevant for shareholders and potential investors are the company's impressive gross profit margins and the fact that it operates with a moderate level of debt. These suggest that Inari Medical is able to effectively manage its finances and might have a cushion to withstand economic fluctuations.

For those looking for a deeper dive into Inari Medical's performance and outlook, there are additional InvestingPro Tips available on their platform. Interested readers can find a total of 10 tips, which could provide further insights into the company's financial nuances. To access these insights, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.